XML 22 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue:    
Premiums and policy fees $ 7,918,235 $ 8,384,604
Ceded reinsurance premiums and policy fees (2,553,010) (2,697,382)
Net investment income 14,141,809 20,811,471 [1]
Other income 280,303 350,519
Revenues before net investment gains (losses) 19,787,337 26,849,212
Net investment gains (losses):    
Other-than-temporary impairments 0 (5,000,000)
Other realized investment gains, net 9,463,843 14,168,911
Change in fair value of equity securities (3,830,793) 33,690,712
Total net investment gains 5,633,050 42,859,623
Total revenues 25,420,387 69,708,835
Benefits, claims and settlement expenses:    
Life 16,089,474 15,703,526
Ceded reinsurance benefits and claims (2,882,312) (2,449,533)
Annuity 1,029,885 1,029,156
Dividends to policyholders 302,685 311,400
Commissions (102,971) (116,571)
Amortization of cost of insurance acquired 661,257 688,348
Operating expenses 8,368,135 10,497,302
Interest expense 28,389 108,722
Total benefits and other expenses 23,494,542 25,772,350
Income before income taxes 1,925,845 43,936,485
Income tax expense (benefit) (144,247) 9,572,139
Net income 2,070,092 34,364,346
Net income attributable to noncontrolling interest (113,397) (106,341)
Net income attributable to common shareholders $ 1,956,695 $ 34,258,005
Amounts attributable to common shareholders:    
Basic income per share (in dollars per share) $ 0.62 $ 10.81
Diluted income per share (in dollars per share) $ 0.62 $ 10.81
Basic weighted average shares outstanding (in shares) 3,176,757 3,167,719
Diluted weighted average shares outstanding (in shares) 3,176,757 3,167,719
[1] The Company has elected to reclassify certain investments to conform with the presentation for the year ended December 31, 2023. These reclassifications had no impact on previously reported net income.